ZA959008B - Competitive progesterone antagonists for demand-oriented female birth control - Google Patents

Competitive progesterone antagonists for demand-oriented female birth control

Info

Publication number
ZA959008B
ZA959008B ZA959008A ZA959008A ZA959008B ZA 959008 B ZA959008 B ZA 959008B ZA 959008 A ZA959008 A ZA 959008A ZA 959008 A ZA959008 A ZA 959008A ZA 959008 B ZA959008 B ZA 959008B
Authority
ZA
South Africa
Prior art keywords
demand
birth control
progesterone antagonists
competitive progesterone
female birth
Prior art date
Application number
ZA959008A
Other languages
English (en)
Inventor
Kristoff Chwalisz
Klaus Stoeckemann
Karin Schmidt-Gollwitzer
Walter Klemann
Original Assignee
Schering Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Ag filed Critical Schering Ag
Publication of ZA959008B publication Critical patent/ZA959008B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/567—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in position 17 alpha, e.g. mestranol, norethandrolone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/568—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone
    • A61K31/569—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone substituted in position 17 alpha, e.g. ethisterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/575—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18—Feminine contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Endocrinology (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Gynecology & Obstetrics (AREA)
  • Reproductive Health (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Investigating Or Analysing Materials By Optical Means (AREA)
ZA959008A 1994-10-24 1995-10-24 Competitive progesterone antagonists for demand-oriented female birth control ZA959008B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4438820 1994-10-24

Publications (1)

Publication Number Publication Date
ZA959008B true ZA959008B (en) 1996-09-16

Family

ID=6532105

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA959008A ZA959008B (en) 1994-10-24 1995-10-24 Competitive progesterone antagonists for demand-oriented female birth control

Country Status (25)

Country Link
US (1) US6143754A (cs)
EP (1) EP0787002B1 (cs)
JP (1) JPH10507461A (cs)
KR (1) KR970706827A (cs)
CN (1) CN1211087C (cs)
AT (1) ATE347894T1 (cs)
AU (1) AU707235B2 (cs)
BG (1) BG62877B1 (cs)
BR (1) BR9509478A (cs)
CA (1) CA2203541A1 (cs)
CZ (1) CZ290690B6 (cs)
DE (1) DE59511071D1 (cs)
DK (1) DK0787002T3 (cs)
ES (1) ES2279515T3 (cs)
FI (1) FI971742A7 (cs)
HU (1) HU226566B1 (cs)
IL (1) IL115738A (cs)
NO (1) NO314437B1 (cs)
NZ (1) NZ295365A (cs)
PL (1) PL319869A1 (cs)
PT (1) PT787002E (cs)
RO (1) RO120606B1 (cs)
SK (1) SK283662B6 (cs)
WO (1) WO1996012494A1 (cs)
ZA (1) ZA959008B (cs)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19745085A1 (de) * 1997-10-11 1999-04-15 Jenapharm Gmbh 11ß-Benzaldoxim-9alpha,10alpha-epoxy-estr-4-en-Derivate, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende pharmazeutische Präparate
DE19809845A1 (de) 1998-03-03 1999-09-09 Jenapharm Gmbh S-substituierte 11beta-Benzaldoxim-estra-4,9-dien-kohlensäurethiolester, Verfahren zu deren Herstellung und diese Verbindungen enthaltende pharmazeutische Zubereitungen
CO5190694A1 (es) * 1999-08-31 2002-08-29 Jenapharm Gmbh And Co Kg Mesoprogestinas (moduladores de receptores de progesterona) como componentes de anticonceptivos femeninos
US7629334B1 (en) 1999-08-31 2009-12-08 Bayer Schering Pharma Aktiengesellschaft Mesoprogrestins (progesterone receptor modulations) as a component of compositions for hormone replacement therapy (HRT)
UA75339C2 (en) * 1999-08-31 2006-04-17 Schering Ag Use of mesoprogestins (progesterone receptor modulators) as pharmaceutical components for manufacture of medicament for hormone replacement therapy (hrt)
DE102005050729A1 (de) * 2005-10-19 2007-04-26 Schering Ag Verfahren zur präventiven bedarfsweisen hormonalen Kontrazeption
US20090170823A1 (en) * 2007-12-20 2009-07-02 Duramed Pharmaceuticals, Inc. Dosage Regimens and Pharmaceutical Compositions and Packages for Emergency Contraception
NZ615430A (en) 2009-04-14 2014-06-27 Laboratoire Hra-Pharma Method for on-demand contraception
CA2758764C (en) * 2009-04-14 2017-04-11 Elizabeth Gray Raymond Method for on-demand contraception using levonorgestrel or norgestrel
CA2913085A1 (en) 2013-05-23 2014-11-27 Bernhard Lindenthal Pharmaceutical composition and the use thereof, and application regime of said pharmaceutical composition for on-demand contraception
HK1246653A1 (zh) 2014-11-17 2018-09-14 Context Biopharma Inc. 奧那司酮延長釋放組合物和方法
JP2018528944A (ja) 2015-09-25 2018-10-04 コンテクスト バイオファーマ インコーポレイテッド オナプリストン中間体の製造方法
MX2018007154A (es) 2015-12-15 2019-01-10 Context Biopharma Inc Composiciones de onapristona amorfa y metodos para hacer las mismas.
US20180148471A1 (en) 2016-11-30 2018-05-31 Arno Therapeutics, Inc. Methods for onapristone synthesis dehydration and deprotection

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5439913A (en) * 1992-05-12 1995-08-08 Schering Aktiengesellschaft Contraception method using competitive progesterone antagonists and novel compounds useful therein

Also Published As

Publication number Publication date
DE59511071D1 (de) 2007-01-25
BR9509478A (pt) 1997-09-30
AU707235B2 (en) 1999-07-08
CZ118097A3 (en) 1997-07-16
SK51897A3 (en) 1997-09-10
ES2279515T3 (es) 2007-08-16
RO120606B1 (ro) 2006-05-30
AU3869695A (en) 1996-05-15
EP0787002B1 (de) 2006-12-13
IL115738A (en) 2002-05-23
FI971742L (fi) 1997-04-23
BG62877B1 (bg) 2000-10-31
EP0787002A1 (de) 1997-08-06
FI971742A0 (fi) 1997-04-23
SK283662B6 (sk) 2003-11-04
NO971869D0 (no) 1997-04-23
NZ295365A (en) 1999-07-29
DK0787002T3 (da) 2007-04-10
WO1996012494A1 (de) 1996-05-02
PT787002E (pt) 2007-03-30
JPH10507461A (ja) 1998-07-21
BG101427A (en) 1997-11-28
HU226566B1 (en) 2009-04-28
FI971742A7 (fi) 1997-04-23
MX9703018A (es) 1997-10-31
US6143754A (en) 2000-11-07
IL115738A0 (en) 1996-01-19
KR970706827A (ko) 1997-12-01
NO971869L (no) 1997-04-23
PL319869A1 (en) 1997-09-01
CN1161649A (zh) 1997-10-08
CZ290690B6 (cs) 2002-09-11
CA2203541A1 (en) 1996-05-02
CN1211087C (zh) 2005-07-20
ATE347894T1 (de) 2007-01-15
NO314437B1 (no) 2003-03-24
HUT77518A (hu) 1998-05-28

Similar Documents

Publication Publication Date Title
IL115738A0 (en) Competitive progesterone antagonists
EP0402950A3 (en) Treatment of postmenopausal disorders
FI963049L (fi) Progesteroniantagonisteja lääkeaineiden valmistamiseksi, jotka on tarkoitettu kohdun toimintahäiriöistä johtuvien verenvuotojen hoitamiseksi
DK0735882T3 (da) Kombinationsprodukt til kontraception indeholdende progesteronantagonister og gestagen
ZA946142B (en) Therapeutic heterocycles
MX9702162A (es) Procedimiento para hacer unidades de dosis mediante granulacion en humedo.
AU3254395A (en) Use of a combination product that contains a competitive progesterone antagonist and a gestagen for the production of a pharmaceutical agent for treating endometriosis or leiomyomata uteri
GB1459675A (en) Method for the prevention of conception
EP0270690A4 (en) MEDICINES FOR THE TREATMENT AND PROPHYLAXIS OF LIVER AND KIDNEY DISEASES.
PT871453E (pt) Preparacao farmaceutica combinada de contracepcao combinada
ATE59960T1 (de) Theophyllintabletten mit verzoegerter freigabe.
IL109076A0 (en) Imidazolo-quinoxalinones, their preparation and pharmaceutical compositions containing them
EP0301850A3 (en) Lhrh antagonist analogs and 19-nor-progestational steroids for therapy
Asbjorn et al. Low dose of gestagen as a contraceptive method. A clinical trial
HUP9900313A1 (hu) Antiösztrogének alkalmazása hím nemzőképesség szabályozására
PT1150683E (pt) Utilizacao de dienogest em doses elevadas
UA23364A (uk) Спосіб лікування гострого ендометриту
Robertson A study of women on the progestogen only pill
UA23363A (uk) Спосіб лікування запальних процесів придатків матки